Blood-based test for the early prediction of Alzheimer‘s disease.
Diadem has raised €10M across 1 funding round from 2 investors, most recently a round in Mar 2022. Based in Brescia, Italy; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-03-29 | Other | €10M |
| CDP Venture Capital,Panakès Partners |
| View deal → |
